Similar articles

• Preclinical behavioral toxicology of inhalant solvents.

  Bowman RE. Bowman RE. NIDA Res Monogr. 1977 Oct;15:200-23. NIDA Res Monogr. 1977. PMID: 416350 No abstract available.
• Volatile substance abuse.

  Flanagan RJ, Ives RJ. Flanagan RJ, et al. Bull Narc. 1994;46(2):49-78. Bull Narc. 1994. PMID: 7866398 Review.
• Childhood histories of attention-deficit hyperactivity disorders in Japanese methamphetamine and inhalant abusers: preliminary report.

  Matsumoto T, Kamijo A, Yamaguchi A, Iseki E, Hirayasu Y. Matsumoto T, et al. Psychiatry Clin Neurosci. 2005 Feb;59(1):102-5. doi: 10.1111/j.1440-1819.2005.01340.x. Psychiatry Clin Neurosci. 2005. PMID: 15679548
• Recognition and prevention of inhalant abuse.

  Anderson CE, Loomis GA. Anderson CE, et al. Am Fam Physician. 2003 Sep 1;68(5):869-74. Am Fam Physician. 2003. PMID: 13678134 Review.
• Clinical, socio-demographic, neurophysiological and neuropsychiatric evaluation of children with volatile substance addiction.

  Uzun N, Kendirli Y. Uzun N, et al. Child Care Health Dev. 2005 Jul;31(4):425-32. doi: 10.1111/j.1365-2214.2005.00526.x. Child Care Health Dev. 2005. PMID: 15948879